-
Merck and Project Data Sphere to join forces to lead Big Data alliance
pharmaceufical-technology
September 12, 2017
Science and technology company Merck and Project Data Sphere are set to collaborate to jointly lead the Global Oncology Big Data Alliance (GOBDA).
-
Merck in agreement with Natrix Separations
expressbpd
September 12, 2017
The acquisition boosts Merck’s single-use chromatography portfolio and accelerates mAb and vaccine manufacturing offering
-
Merck to co-lead Big Data alliance
pharmatimes
September 12, 2017
Merck will join forces with Project Data Sphere – an independent, not-for-profit initiative of the CEO Roundtable on Cancer's Life Sciences Consortium – to jointly lead the Global Oncology Big Data Alliance (GOBDA).
-
Merck set to join forces with Project Data Sphere to pioneer Global Oncology Big Data Alliance
worldpharmanews
September 12, 2017
Merck, a leading science and technology company has announced that it will enter into a strategic collaboration with Project Data Sphere LLC
-
Merck joins forces to pioneer global oncology big data initiative
europeanpharmaceuticalreview
September 12, 2017
Merck has announced that it will enter into a strategic collaboration with Project Data Sphere LLC, for oncology innovations…
-
Merck 'Grant for Oncology Innovation' Awards Recognize Recipients for Pushing Boundaries in Oncology
prnasia
September 11, 2017
Merck, a leading science and technology company, today announced recipients of the fourth annual Grant for Oncology Innovation (GOI) awards.
-
Deals this week: Mundipharma Medical Company, Cooper Pharmal Sarl, Merck
pharmaceufical-technology
September 08, 2017
Janssen is a Johnson & Johnson subsidiary based in Belgium.
-
Merck KGaA commits to continued partnership with Ugandan Government
pharmafile
September 06, 2017
Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit subsidiary Merck Foundation to build healthcare capacity and treatment access in the region
-
Merck still mulling over filing CETP med as it posts 'lackluster' data
fiercepharma
August 30, 2017
Anacetrapib is designed to ward off heart attacks and strokes by blocking the protein CETP and thus boosting “good,” cholesterol
-
Merck collaborates with angiex to speed clinical readiness of new cancer therapy
worldpharmanews
August 30, 2017
Merck, a leading science and technology company, today announced a new collaboration with Angiex, Inc., Cambridge, Massachusetts, USA to support the biotechnology start-up's ability to speed its lead oncology antibody drug candidate to clinical use.